(firstQuint)Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT.

 [18F]FTP is a novel radioactive tracer that has shown potential in labeling dopamine D3 receptors through PET/CT imaging.

 This is a phase 1 study design meant to evaluate safety, biodistribution and brain uptake of [18F]FTP in healthy volunteers.

.

 Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT@highlight

In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer [18F]Fluortriopride ([18F]FTP).

